Clinical Trial Update: Lemborexant in Delayed Sleep Phase Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating lemborexant for delayed sleep phase disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Sleep Phase Disorder

Drugs mentioned

• Lemborexant (Dayvigo) (lemborexant)

Snippet

Sponsor: Stanford University | Conditions: Delayed Sleep Phase Syndrome | Phase 4 | Status: COMPLETED